Company / Operating Cash Flow per Share
Revolution Medicines, Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$4.83
FY2025
5-year range
-$4.83 / -$0.74
FY2021-FY2025
Trend
-42.7%
vs FY2024
Sector context
#196 of 212
Health Care
What the data says
Among 212 Health Care companies, Revolution Medicines, Inc. is in the bottom 8% for operating cash flow per share. Operating Cash Flow per Share has fluctuated over the past 8 years, ranging from $-17.90 in FY2019 to $0.53 in FY2018.
Based on SEC 10-K filings.
-4.83 in FY2025.
Declined from $-3.88 to $-4.83 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 212This company -$4.83 Sector average $5.28
▼
-191.5% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 42.7% year-over-year.
- Ranks #196 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2018.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.83 | -42.7% |
| FY2024 | -$3.39 | +12.7% |
| FY2023 | -$3.88 | -187.3% |
| FY2022 | -$1.35 | -81.2% |
| FY2021 | -$0.74 | -302.2% |
| FY2020 | $0.37 | +102.1% |
| FY2019 | -$17.90 | -3491.4% |
| FY2018 | $0.53 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026